Global mortality impact of the 1957-1959 influenza pandemic

Cécile Viboud, Lone Simonsen, Rodrigo Fuentes, Jose Flores, Mark A. Miller, Gerardo Chowell

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background. Quantitative estimates of the global burden of the 1957 influenza pandemic are lacking. Here we fill this gap by modeling historical mortality statistics. Methods. We used annual rates of age- and cause-specific deaths to estimate pandemic-related mortality in excess of background levels in 39 countries in Europe, the Asia-Pacific region, and the Americas. We modeled the relationship between excess mortality and development indicators to extrapolate the global burden of the pandemic. Results. The pandemic-associated excess respiratory mortality rate was 1.9/10 000 population (95% confidence interval [CI], 1.2-2.6 cases/10 000 population) on average during 1957-1959. Excess mortality rates varied 70-fold across countries; Europe and Latin America experienced the lowest and highest rates, respectively. Excess mortality was delayed by 1-2 years in 18 countries (46%). Increases in the mortality rate relative to baseline were greatest in school-aged children and young adults, with no evidence that elderly population was spared from excess mortality. Development indicators were moderate predictors of excess mortality, explaining 35%-77% of the variance. Overall, we attribute 1.1 million excess deaths (95% CI, .7 million-1.5 million excess deaths) globally to the 1957-1959 pandemic. Conclusions. The global mortality rate of the 1957-1959 influenza pandemic was moderate relative to that of the 1918 pandemic but was approximately 10-fold greater than that of the 2009 pandemic. The impact of the pandemic on mortality was delayed in several countries, pointing to a window of opportunity for vaccination in a future pandemic.

Original languageEnglish (US)
Pages (from-to)738-745
Number of pages8
JournalJournal of Infectious Diseases
Volume212
Issue number11
DOIs
StatePublished - 2016
Externally publishedYes

Fingerprint

Pandemics
Human Influenza
Mortality
Confidence Intervals
Population
Latin America
Respiratory Rate
Young Adult
Cause of Death
Vaccination

Keywords

  • Development indicators
  • Global disease burden
  • Health indicators
  • Historical studies
  • Models
  • Mortality rates
  • Pandemic influenza
  • Pandemic planning.
  • Severity
  • Vital statistics

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

Viboud, C., Simonsen, L., Fuentes, R., Flores, J., Miller, M. A., & Chowell, G. (2016). Global mortality impact of the 1957-1959 influenza pandemic. Journal of Infectious Diseases, 212(11), 738-745. https://doi.org/10.1093/infdis/jiv534

Global mortality impact of the 1957-1959 influenza pandemic. / Viboud, Cécile; Simonsen, Lone; Fuentes, Rodrigo; Flores, Jose; Miller, Mark A.; Chowell, Gerardo.

In: Journal of Infectious Diseases, Vol. 212, No. 11, 2016, p. 738-745.

Research output: Contribution to journalArticle

Viboud, C, Simonsen, L, Fuentes, R, Flores, J, Miller, MA & Chowell, G 2016, 'Global mortality impact of the 1957-1959 influenza pandemic', Journal of Infectious Diseases, vol. 212, no. 11, pp. 738-745. https://doi.org/10.1093/infdis/jiv534
Viboud C, Simonsen L, Fuentes R, Flores J, Miller MA, Chowell G. Global mortality impact of the 1957-1959 influenza pandemic. Journal of Infectious Diseases. 2016;212(11):738-745. https://doi.org/10.1093/infdis/jiv534
Viboud, Cécile ; Simonsen, Lone ; Fuentes, Rodrigo ; Flores, Jose ; Miller, Mark A. ; Chowell, Gerardo. / Global mortality impact of the 1957-1959 influenza pandemic. In: Journal of Infectious Diseases. 2016 ; Vol. 212, No. 11. pp. 738-745.
@article{71e7fd1e80fb4beebe1c1639235b291d,
title = "Global mortality impact of the 1957-1959 influenza pandemic",
abstract = "Background. Quantitative estimates of the global burden of the 1957 influenza pandemic are lacking. Here we fill this gap by modeling historical mortality statistics. Methods. We used annual rates of age- and cause-specific deaths to estimate pandemic-related mortality in excess of background levels in 39 countries in Europe, the Asia-Pacific region, and the Americas. We modeled the relationship between excess mortality and development indicators to extrapolate the global burden of the pandemic. Results. The pandemic-associated excess respiratory mortality rate was 1.9/10 000 population (95{\%} confidence interval [CI], 1.2-2.6 cases/10 000 population) on average during 1957-1959. Excess mortality rates varied 70-fold across countries; Europe and Latin America experienced the lowest and highest rates, respectively. Excess mortality was delayed by 1-2 years in 18 countries (46{\%}). Increases in the mortality rate relative to baseline were greatest in school-aged children and young adults, with no evidence that elderly population was spared from excess mortality. Development indicators were moderate predictors of excess mortality, explaining 35{\%}-77{\%} of the variance. Overall, we attribute 1.1 million excess deaths (95{\%} CI, .7 million-1.5 million excess deaths) globally to the 1957-1959 pandemic. Conclusions. The global mortality rate of the 1957-1959 influenza pandemic was moderate relative to that of the 1918 pandemic but was approximately 10-fold greater than that of the 2009 pandemic. The impact of the pandemic on mortality was delayed in several countries, pointing to a window of opportunity for vaccination in a future pandemic.",
keywords = "Development indicators, Global disease burden, Health indicators, Historical studies, Models, Mortality rates, Pandemic influenza, Pandemic planning., Severity, Vital statistics",
author = "C{\'e}cile Viboud and Lone Simonsen and Rodrigo Fuentes and Jose Flores and Miller, {Mark A.} and Gerardo Chowell",
year = "2016",
doi = "10.1093/infdis/jiv534",
language = "English (US)",
volume = "212",
pages = "738--745",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Global mortality impact of the 1957-1959 influenza pandemic

AU - Viboud, Cécile

AU - Simonsen, Lone

AU - Fuentes, Rodrigo

AU - Flores, Jose

AU - Miller, Mark A.

AU - Chowell, Gerardo

PY - 2016

Y1 - 2016

N2 - Background. Quantitative estimates of the global burden of the 1957 influenza pandemic are lacking. Here we fill this gap by modeling historical mortality statistics. Methods. We used annual rates of age- and cause-specific deaths to estimate pandemic-related mortality in excess of background levels in 39 countries in Europe, the Asia-Pacific region, and the Americas. We modeled the relationship between excess mortality and development indicators to extrapolate the global burden of the pandemic. Results. The pandemic-associated excess respiratory mortality rate was 1.9/10 000 population (95% confidence interval [CI], 1.2-2.6 cases/10 000 population) on average during 1957-1959. Excess mortality rates varied 70-fold across countries; Europe and Latin America experienced the lowest and highest rates, respectively. Excess mortality was delayed by 1-2 years in 18 countries (46%). Increases in the mortality rate relative to baseline were greatest in school-aged children and young adults, with no evidence that elderly population was spared from excess mortality. Development indicators were moderate predictors of excess mortality, explaining 35%-77% of the variance. Overall, we attribute 1.1 million excess deaths (95% CI, .7 million-1.5 million excess deaths) globally to the 1957-1959 pandemic. Conclusions. The global mortality rate of the 1957-1959 influenza pandemic was moderate relative to that of the 1918 pandemic but was approximately 10-fold greater than that of the 2009 pandemic. The impact of the pandemic on mortality was delayed in several countries, pointing to a window of opportunity for vaccination in a future pandemic.

AB - Background. Quantitative estimates of the global burden of the 1957 influenza pandemic are lacking. Here we fill this gap by modeling historical mortality statistics. Methods. We used annual rates of age- and cause-specific deaths to estimate pandemic-related mortality in excess of background levels in 39 countries in Europe, the Asia-Pacific region, and the Americas. We modeled the relationship between excess mortality and development indicators to extrapolate the global burden of the pandemic. Results. The pandemic-associated excess respiratory mortality rate was 1.9/10 000 population (95% confidence interval [CI], 1.2-2.6 cases/10 000 population) on average during 1957-1959. Excess mortality rates varied 70-fold across countries; Europe and Latin America experienced the lowest and highest rates, respectively. Excess mortality was delayed by 1-2 years in 18 countries (46%). Increases in the mortality rate relative to baseline were greatest in school-aged children and young adults, with no evidence that elderly population was spared from excess mortality. Development indicators were moderate predictors of excess mortality, explaining 35%-77% of the variance. Overall, we attribute 1.1 million excess deaths (95% CI, .7 million-1.5 million excess deaths) globally to the 1957-1959 pandemic. Conclusions. The global mortality rate of the 1957-1959 influenza pandemic was moderate relative to that of the 1918 pandemic but was approximately 10-fold greater than that of the 2009 pandemic. The impact of the pandemic on mortality was delayed in several countries, pointing to a window of opportunity for vaccination in a future pandemic.

KW - Development indicators

KW - Global disease burden

KW - Health indicators

KW - Historical studies

KW - Models

KW - Mortality rates

KW - Pandemic influenza

KW - Pandemic planning.

KW - Severity

KW - Vital statistics

UR - http://www.scopus.com/inward/record.url?scp=84958600424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958600424&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiv534

DO - 10.1093/infdis/jiv534

M3 - Article

AN - SCOPUS:84958600424

VL - 212

SP - 738

EP - 745

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 11

ER -